
Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis
0:00
6:59
The poster was presented by Dr. Lebwohl and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.
This audio commentary is provided by Dr. Steve Feldman.
Mais episódios de "Research Developments in Atopic Dermatitis"



Não percas um episódio de “Research Developments in Atopic Dermatitis” e subscrevê-lo na aplicação GetPodcast.








